Gynaecological cancer: New targets and immunotherapy developments

Immunotherapy in NSCLC: Adjuvant and neoadjuvant clinical scenarios

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer

Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite stable colorectal cancer

Rationale for routine use of IORT for early breast cancer and data for specific indications

Hormonal Therapy and Complications

Survivorship Recommendations for Sexual and Gender Minorities

The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer

Lisocabtagene maraleucel is efficacious at treating R/R chronic lymphocytic leukaemia/small lymphocytic lymphoma

ASCO 2023: Lung cancer research highlights

Real-world use of brexu-cel shows benefit in R/R mantle cell lymphoma treatment